Education
About Us
Working with TipRanks
Follow Us
ReproCELL Inc. (JP:4978)
:4978
4978 Stock Chart & Stats
¥140.00
¥3.00(2.91%)
At close: 4:00 PM EST
¥140.00
¥3.00(2.91%)
Day’s Range― - ―
52-Week Range¥98.00 - ¥277.00
Previous CloseN/A
Volume331.50K
Average Volume (3M)510.74K
Market Cap
¥13.27B
Enterprise Value¥12.62B
Total Cash (Recent Filing)¥4.72B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.93
Shares Outstanding94,802,895
10 Day Avg. Volume504,660
30 Day Avg. Volume510,736
Financial Highlights & Ratios
PEG Ratio-0.33
Price to Book (P/B)1.52
Price to Sales (P/S)4.58
P/FCF Ratio-169.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)124.77
Revenue Forecast (FY)¥494.39B
4978 FAQ
What was ReproCELL Inc.’s price range in the past 12 months?
ReproCELL Inc. lowest stock price was ¥98.00 and its highest was ¥277.00 in the past 12 months.
What is ReproCELL Inc.’s market cap?
ReproCELL Inc.’s market cap is ¥13.27B.
When is ReproCELL Inc.’s upcoming earnings report date?
ReproCELL Inc.’s upcoming earnings report date is Feb 06, 2026 which is in 44 days.
How were ReproCELL Inc.’s earnings last quarter?
ReproCELL Inc. released its earnings results on Nov 13, 2025. The company reported -¥1.93 earnings per share for the quarter, missing the consensus estimate of N/A by -¥1.93.
Is ReproCELL Inc. overvalued?
According to Wall Street analysts ReproCELL Inc.’s price is currently Overvalued.
Does ReproCELL Inc. pay dividends?
ReproCELL Inc. does not currently pay dividends.
What is ReproCELL Inc.’s EPS estimate?
ReproCELL Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ReproCELL Inc. have?
ReproCELL Inc. has 94,802,895 shares outstanding.
What happened to ReproCELL Inc.’s price movement after its last earnings report?
ReproCELL Inc. reported an EPS of -¥1.93 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.326%.
Which hedge fund is a major shareholder of ReproCELL Inc.?
Currently, no hedge funds are holding shares in JP:4978
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ReproCELL Inc.
ReproCELL Inc. (4978) is a biotechnology company based in Japan that specializes in stem cell research and development. The company provides a broad range of products and services focused on drug discovery support, including human cell-based assays, reagents, and 3D cell culture products. ReproCELL's offerings cater to the pharmaceutical and academic research sectors, helping scientists and organizations accelerate their research and development processes.
Technical Analysis
StemRIM Inc.
―
CellSource Co., Ltd.
―
StemCell Institute
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―
Options Prices
Currently, No data available
---